Globus Medical, Inc.
GMED
$76.64
-$0.57-0.74%
NYSE
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -8.05% | 7.46% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -8.05% | 7.46% | |||
| Cost of Revenue | -8.07% | 3.45% | |||
| Gross Profit | -8.05% | 9.35% | |||
| SG&A Expenses | -2.30% | 7.25% | |||
| Depreciation & Amortization | 0.57% | -1.62% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -4.33% | 4.46% | |||
| Operating Income | -19.61% | 17.96% | |||
| Income Before Tax | -7.18% | 17.53% | |||
| Income Tax Expenses | 14.43% | 14.43% | |||
| Earnings from Continuing Operations | -11.59% | 18.18% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -11.59% | 18.18% | |||
| EBIT | -19.61% | 17.96% | |||
| EBITDA | -14.20% | 11.69% | |||
| EPS Basic | -12.21% | 18.26% | |||
| Normalized Basic EPS | -16.20% | 14.40% | |||
| EPS Diluted | -11.77% | 15.92% | |||
| Normalized Diluted EPS | -16.59% | 13.34% | |||
| Average Basic Shares Outstanding | 0.71% | -0.07% | |||
| Average Diluted Shares Outstanding | 1.18% | 0.87% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||